Humacyte, Inc.HUMA
Price (close)
$0.57
Market cap
$158.0M
P/E
—
Revenue (TTM)
$2.1M
Net income
-$96.7M
Dividend yield
—
1-year total return
-64.7%
Net margin
-4560.8%
Revenue growth
159.3%
Debt / equity
1.16x
What Humacyte, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 | $2.0M |
| Net income | -$66.5M | -$26.5M | -$12.0M | -$110.8M | -$148.7M | -$40.8M |
| Free cash flow | -$55.9M | -$81.4M | -$72.2M | -$75.6M | -$99.7M | -$105.9M |
More on HUMA.
- Humacyte, Inc. summary
- Humacyte, Inc. financial statements
- Humacyte, Inc. key metrics
- Humacyte, Inc. health scores and style box
- Humacyte, Inc. earnings
- Humacyte, Inc. dividends
- Humacyte, Inc. valuation
- Humacyte, Inc. ownership and insiders
- Humacyte, Inc. peers
Figures from Humacyte, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.